Investing.com - Novo Nordisk ADR (NYSE: NVO) reported fourth quarter EPS of $0.88, $0.05 better than the analyst estimate of $0.83. Revenue for the quarter came in at $7.06B versus...
By Geoffrey Smith Investing.com -- The Fed is set to raise interest rates by another 25 basis points, with all eyes on how chair Jerome Powell responds later to speculation on a...
Converting mutual funds to ETFs is an emerging trend ETFs offer flexible trading and more transparency 2 JP Morgan ETFs worth a look The conversion of mutual funds into...
Inflation worries continue to weigh on equity markets Earnings season will likely increase volatility ETFs offer investors ability to diversify Earnings season has started with...
Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US...
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
| Average | 1,010.89 (+632.16% Upside) |
| High | 1,093.00 |
| Low | 855.816 |
| Price | 138.07 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Sell | Strong Buy | Sell | Strong Buy |
| Summary | Neutral | Neutral | Strong Buy | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 66.26 | 69.54 | 65.49 | -4.21 | -5.97% | 4.32M | NYSE | |||
| 5.94 | 6.61 | 5.88 | -0.14 | -2.30% | 15.41M | NYSE | |||
| 194.76 | 198.17 | 189.92 | +4.78 | +2.52% | 185.21M | NASDAQ | |||
| 43.76 | 44.30 | 43.72 | -0.30 | -0.68% | 18.06M | NYSE | |||
| 61.57 | 62.56 | 61.14 | -1.27 | -2.02% | 444.81K | NYSE | |||
| 5.39 | 5.53 | 5.26 | -0.32 | -5.60% | 2.05M | NYSE | |||
| 83.68 | 86.28 | 83.22 | -2.41 | -2.80% | 52.81M | NASDAQ | |||
| 136.18 | 136.32 | 134.95 | -0.76 | -0.56% | 4.83M | NYSE | |||
| 229.44 | 230.26 | 228.04 | -0.69 | -0.30% | 3.24M | NYSE | |||
| 24.69 | 24.80 | 24.61 | -0.15 | -0.60% | 34.89K | NYSE | |||
| 171.82 | 172.38 | 169.59 | +2.70 | +1.60% | 5.55M | NASDAQ | |||
| 102.18 | 103.95 | 100.65 | -1.21 | -1.17% | 80.80M | NASDAQ | |||
| 218.44 | 226.27 | 216.05 | -3.54 | -1.59% | 1.33M | NASDAQ | |||
| 0.8084 | 0.871 | 0.771 | +0.0080 | +1.00% | 7.55M | NASDAQ | |||
| 42.95 | 43.10 | 42.16 | -0.21 | -0.49% | 11.02M | NYSE |